Modulations of brain amines and dopaminergic behavior by a novel, reversible and selective MAO-B inhibitor

Brain Research

Volumn 1470, Issue , 2012, Pages 45-51

  Mishra, Nibha ^a   Sasmal, Dinakar ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

2 Phenylethylamine; Dopamine; Monoamine oxidase B inhibitor; NP 9; Reserpine

Indexed keywords

3 (ANTHRACEN 10 YL) 5 (3 NITROPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BRAIN AMINE; DOPAMINE; GLUTATHIONE; MONOAMINE OXIDASE B INHIBITOR; PHENETHYLAMINE; RESERPINE; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG SAFETY; DRUG STRUCTURE; DYSKINESIA; ENZYME ACTIVITY; ENZYME INHIBITION; IN VIVO STUDY; LD 50; MEAN ARTERIAL PRESSURE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

AMINES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLUTATHIONE; MALE; MICE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PHENETHYLAMINES; PYRAZOLONES; RESERPINE; SELEGILINE; STEREOTYPED BEHAVIOR;

EID: 84864595998     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.06.037     Document Type: Article

References (34)

1. Z.A. Abassi, O. Binah, and M.B.H. Youdim Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline Br. J. Pharmacol. 143 2004 371 378 (Pubitemid 39424825)
2. V.C. Abílio, C. Araujo, M. Bergamo, P.R.V. Calvente, V. D′Almeida, R.A. Ribeiro, and R. Frussa-Filho Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 109 114 (Pubitemid 36126651)
3. N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, and A. Le Kim SL25. 1131 [3 (S), 3a (S)-3-Methoxymethyl-7-[4, 4, 4-trifluorobutoxy]-3, 3a, 4, 5-tetrahydro-1, 3-oxazolo [3, 4-a] quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile J. Pharmacol. Exp. Ther. 310 2004 1171 1182
4. C. Binda, P. Newton-Vinson, F. Hubálek, D.E. Edmondson, and A. Mattevi Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders Nat. Struct. Mol. Biol. 9 2001 22 26
5. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
6. C. Braestrup, H. Andersen, and A. Randrup The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation Eur. J. Pharmacol. 34 1975 181 187
7. R.D. Bruce An up-and-down procedure for acute toxicity testing Fundam. Appl. Toxicol. 5 1985 151 157 (Pubitemid 15164325)
8. D. Burden, and S. Philips Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain J. Neurochem. 34 1980 1725 1732 (Pubitemid 10114416)
9. J.C. Delumeau, D. Bentue-Ferrer, J.M. Gandon, R. Amrein, S. Belliard, and H. Allain Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases J. Neural Transm. 41 1994 259 266 (Pubitemid 24215700)
10. J.P.M. Finberg, and M.B.H. Youdim Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours Neuropharmacology 43 2002 1110 1118 (Pubitemid 36009364)
11. C.J. Fowler, and S.B Ross Selective inhibitors of monoamine oxidase A and B: biochemical, pharmacological, and clinical properties Med. Res. Rev. 4 1984 323 358 (Pubitemid 14073188)
12. C.J. Fowler, A. Wiberg, L. Oreland, J. Marcusson, and B. Winblad The effect of age on the activity and molecular properties of human brain monoamine oxidase J. Neural Transm. 49 1980 1 20 (Pubitemid 10030548)
13. A.L. Green, and M.A.S. El Hait A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to ()-amphetamine, p-methoxy amphetamine and harmaline Biochem. Pharmacol. 29 1980 2781 2789 (Pubitemid 10021154)
14. A.L Green Assessment of the potency of reversible MAO inhibitors in vivo K.F. Tipton, P. Dostert, M. Strolin-Benedetti, Monoamine Oxidase and Disease: Prospects for Therapy With Reversible Inhibitors 1984 Academic Press London 73 81
15. A. Holt, D.F. Sharman, G.B. Baker, and M.M. Palcic A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates Anal. Biochem. 244 1997 384 392 (Pubitemid 27043336)
16. A. Horita, and C. Chinn An analysis of the interaction of reversible and irreversible monoamine oxidase inhibitors Biochem. Pharmacol. 13 1964 371 378
17. D. Horwitz, W. Lovenberg, K. Engelman, and A. Sjoerdsma Monoamine oxidase inhibitors, tyramine, and cheese J. Am. Med. Assoc. 188 1964 1108 1110
18. I. Lamensdorf, S. Porat, R. Simantov, and J.P.M. Finberg Effect of low dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine induced dopamine release in vivo Br. J. Pharmacol. 126 1999 997 1002 (Pubitemid 29103716)
19. W.P. Melega, A.K. Cho, D. Schmitz, R. Kuczenski, and D.S. Segal l-Methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine J. Pharmacol. Exp. Ther. 288 1999 752 758 (Pubitemid 29119691)
20. N. Mishra, and D. Sasmal Development of selective and reversible pyrazoline based MAO-B inhibitors: virtual screening, synthesis and biological evaluation Bioorg. Med. Chem. Lett. 21 2011 1969 1973
21. J.A. Morón, V. Pérez, M. Pastó, J.M. Lizcano, and M. Unzeta FA-70, a novel selective and irreversible monoamine oxidase-A inhibitor: effect on monoamine metabolism in mouse cerebral cortex J. Pharmacol. Exp. Ther. 292 2000 788 794 (Pubitemid 30067445)
22. R. Ortmann, M. Schaub, A. Felner, J. Lauber, P. Christen, and P. Waldmeier Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors Psychopharmacology 84 1984 22 27 (Pubitemid 14032202)
23. V. Perez, and M. Unzeta PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice Neurochem. Int. 42 2003 221 229 (Pubitemid 35335694)
24. F. Ponzio, G. Achilli, G. Calderini, P. Ferretti, C. Perego, G. Toffano, and S. Algeri Depletion and recovery of neuronal monoamine storage in rats of different ages treated with reserpine Neurobiol. Aging 5 1984 101 104 (Pubitemid 14009175)
25. A. Rajeswari, and M. Sabesan Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice Inflammopharmacology 16 2008 96 99 (Pubitemid 351521747)
26. D. Secci, A. Bolasco, P. Chimenti, and S. Carradori The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/ anticonvulsant agents Curr. Med. Chem. 18 2011 5114 5144
27. J. Sedlak, and R.H. Lindsay Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent Anal. Biochem. 25 1968 192 205
28. F. Stocchi, L. Vacca, P. Grassini, M. De Pandis, G. Battaglia, C. Cattaneo, and R. Fariello Symptom relief in Parkinson disease by safinamide Neurology 67 2006 S24 S29
29. K.F. Tipton, M. Strolin-Benedetti, J. McCrodden, T. Boucher, and C.J Fowler The inhibition of rat liver monoamine oxidase-B by the enantiomers of MD 780236 K.F. Tipton, P. Dostert, M. Strolin-Benedetti, Monoamine Oxidase and Disease: Prospects for Therapy With Reversible Inhibitors 1984 Academic Press London 155 163
30. S. Turkish, P. Yu, and A. Greenshaw Monoamine oxidase-B inhibition: a comparison of in vivo and ex vivo measures of reversible effects J. Neural Transm. 74 1988 141 148
31. P.C. Waldmeier, A.E. Felner, and J. Lauber Reversible monoamine oxidase inhibitors: relation between effects on enzymatic activity measured ex vivo and on amine activity K.F. Tipton, P. Dostert, M. Strolin-Benedetti, Monoamine Oxidase and Disease: Prospects for Therapy With Reversible Inhibitors 1984 Academic Press London 108 116
32. M.B. Youdim, D. Edmondson, and K.F. Tipton The therapeutic potential of monoamine oxidase inhibitors Nat. Rev. Neurosci. 7 2006 295 309
33. M.B.H. Youdim, A. Gross, and J.P.M. Finberg Rasagiline [Npropargyl1R ()aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B Br. J. Pharmacol. 132 2001 500 506 (Pubitemid 32142364)
34. P.H. Yu, B.A. Davis, A.A. Boulton, and D.M. Zuo Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications J. Neural Transm. 41 1994 397 406 (Pubitemid 24215719)